Author:
Nicolas Laurent B.,Gutierrez Marcelo M.,Binkert Christoph,Dingemanse Jasper
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference18 articles.
1. Ma TK, Kam KK, Yan BP, Lam YY (2010) Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 160(6):1273–1292
2. Perret-Guillaume C, Joly L, Jankowski P, Benetos A (2009) Benefits of the RAS blockade: clinical evidence before the ONTARGET study. J Hypertens Suppl 27(2):S3–S7
3. Bing J (1973) Rapid marked increase in plasma renin in rats treated with inhibitors of the renin system. Effects of 1-sar-8-ala-angiotensin II and of a synthetic converting enzyme inhibitor (nonapeptide, SQ 20.881) on normal and adrenalectomized rats. Acta Pathol Microbiol Scand A 81(3):376–378
4. Doggrell SA, Wanstall JC (2004) Vascular chymase: pathophysiological role and therapeutic potential of inhibition. Cardiovasc Res 61(1):653–662
5. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A (1998) Plasma bradykinin in angio-oedema. Lancet 351:1693–1697
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献